Todd Anderson alias Dr. Secondhand Science

Todd Anderson is not licensed or approved by Minnesota Board of Chiropractic Examiners to diagnose, treat, or cure Autoimmunity.

Autoimmunity

Supports

There is currently no high-quality evidence (systematic reviews, large RCTs, major guidelines) showing that chiropractic treatment has clinically meaningful benefits on autoimmune diseases themselves (e.g., reducing disease activity, preventing flares, inducing remission, or altering long‑term outcomes). Systematic reviews of spinal manipulative therapy (SMT) and immune-related outcomes report at most short‑term changes in immune or stress biomarkers without demonstrated clinical benefit on immune-mediated or infectious diseases, and they explicitly conclude that clinical evidence to support or refute claims of disease prevention or treatment via immune modulation is lacking. Recent randomized trials show that chiropractic adjustments can change certain circulating biomarkers (e.g., IL‑6, TNF‑α, BDNF, cortisol), but these studies involve small samples, focus on nonspecific musculoskeletal or stress-related contexts, and do not study autoimmune diagnoses or hard clinical endpoints. Major autoimmune disease management evidence (e.g., vitamin D and omega‑3 RCTs for autoimmune disease prevention^[16], immunomodulatory biologics^[19], mesenchymal stem cell transplantation^[18], and guideline‑based therapies for inflammatory bowel disease nutrition^[2]) highlights pharmacologic and nutritional strategies and does not include chiropractic as a disease-modifying treatment.

Contradicts

The best available evidence explicitly contradicts strong claims that chiropractic treatment can effectively treat autoimmunity or meaningfully boost immune function in a clinically relevant way. A systematic review in JAMA Network Open found no acceptable- or high-quality randomized trials showing that spinal manipulative therapy changes immune system outcomes in a way that prevents or treats infectious disease, and concluded there is no clinical evidence to support or refute such immune claims. Consensus statements from chiropractic researchers similarly state there is no valid clinical scientific evidence that chiropractic care impacts the immune system to prevent common illnesses. Narrative reviews and research bulletins from chiropractic organizations summarize that existing laboratory and small experimental studies on immune markers after spinal manipulation are contradictory, underpowered, and do not justify clinical claims of enhanced immunity. Importantly, none of the major autoimmune-related RCTs and guidelines—such as the VITAL trial showing modest autoimmune disease prevention with vitamin D and marine omega-3 fatty acids^[16], the mesenchymal stem cell meta‑analysis for several autoimmune diseases^[18], or guidelines on clinical nutrition in inflammatory bowel disease emphasizing diet, enteral/parenteral nutrition, and immunosuppressive therapy^[2]—include chiropractic or spinal manipulation as a recommended treatment or modifier of autoimmune disease course. This absence in disease‑specific guidelines and high‑quality trials is a strong signal that evidence supporting chiropractic as a treatment for autoimmunity is weak to nonexistent.

Mainstream view

The mainstream medical and scientific position is that autoimmune diseases are managed with evidence‑based pharmacologic therapies (e.g., immunosuppressants, biologics, targeted small molecules), lifestyle modification, and adjunctive supportive measures such as appropriate nutrition, vaccination, and management of comorbidities, guided by specialty society and organ‑specific guidelines^[2][18][19]. Chiropractic care is not recognized as a disease‑modifying treatment for autoimmunity and is absent from major guidelines on autoimmune conditions, which instead focus on immune‑targeting drugs, nutritional support, and cardiovascular risk reduction in autoimmune and inflammatory populations^{[2][18][19][22]}. Chiropractic or spinal manipulation may have a role as supportive care for mechanical pain or musculoskeletal complaints in some patients, but using chiropractic treatment with the expectation of directly treating autoimmunity, altering immune dysregulation, or preventing autoimmune disease is not supported by current high‑quality evidence and is considered outside mainstream, guideline‑based care.

In their own wordsView sourceArchived copy

“Autoimmunity”

Rule: Minn. Stat. § 148.01, subd. 1

See every doc bro advertising Autoimmune disease

Todd Anderson is not licensed or approved by Minnesota Board of Chiropractic Examiners to diagnose, treat, or cure Thyroid Support.

Thyroid Support

Supports

High-quality evidence specifically supporting a broad claim of generic thyroid support is limited. ^[6] One randomized-trial meta-analysis found that long-term exercise-based interventions can improve some thyroid-function measures in people with hypothyroidism, suggesting exercise may be a useful adjunct in selected patients . ^[14] A 2025 systematic review and meta-analysis reported that a gluten-free diet may improve some outcomes in non-celiac Hashimoto’s thyroiditis, but this is a narrow subgroup finding rather than evidence for thyroid support in general . ^[13][15]

Contradicts

The claim is too vague to be directly supported as stated, and there is no major guideline or broad systematic review in the provided index list endorsing unspecified thyroid support for the general population. ^[13] The exercise meta-analysis applies only to hypothyroidism and addresses function, not an all-purpose thyroid-support intervention . ^[14] The gluten-free diet meta-analysis applies only to non-celiac Hashimoto’s thyroiditis and does not establish benefit for people without that condition or for thyroid health broadly . ^[15] The remaining indexed papers are unrelated to thyroid support and do not provide evidentiary backing for the claim.

Mainstream view

Mainstream endocrinology does not recognize a generic thyroid support intervention as an evidence-based medical category. Evidence-based care focuses on diagnosing and treating specific thyroid disorders, correcting identified deficiencies when present, and using standard therapies such as levothyroxine for hypothyroidism or condition-specific management for other thyroid diseases. ^{[1][13][14][5]} Lifestyle measures may be adjunctive in selected patients, but broad thyroid-support claims are not supported as a general medical recommendation.

In their own wordsView sourceArchived copy

“Thyroid Support”

Rule: Minn. Stat. § 148.01, subd. 1

See every doc bro advertising Thyroid disease and Hashimoto

Todd Anderson is not licensed or approved by Minnesota Board of Chiropractic Examiners to diagnose, treat, or cure Hormone Balance.

Hormone Balance

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Hormone Balance”

Rule: Minn. Stat. § 148.01, subd. 1

See every doc bro advertising Hormone imbalance and replacement

Todd Anderson is not licensed or approved by Minnesota Board of Chiropractic Examiners to diagnose, treat, or cure Reverse autoimmune conditions.

Reverse autoimmune conditions

Supports

High-quality literature supports a narrower version of the claim: some autoimmune diseases can enter sustained remission, and in selected contexts immune “reset” or functional cure may be possible. ^[17][18][20] Reviews and expert statements describe durable remission after trigger removal, immune reconstitution, or advanced cell therapies in selected patients, especially in refractory disease and in limited disease-specific scenarios. Guidelines for autoimmune conditions commonly set treatment goals as remission or low disease activity rather than cure, and some diseases can have treatment-free remission after adequate therapy, as reflected in autoimmune hepatitis and Graves’ disease literature . ^[19]

Contradicts

The broad claim “Reverse autoimmune conditions” is too strong and is not supported as a general statement across autoimmune diseases. ^[18][19][20] Most evidence shows control, remission, or relapse reduction rather than true reversal, and durable drug-free remission is uncommon outside selected diseases and specialized interventions. The strongest supportive publications are narrative reviews, expert statements, case series, or disease-specific guidance, not universal randomized evidence proving reversal of autoimmunity as a class. The index papers provided do not directly establish reversal of autoimmune disease; they mainly concern unrelated conditions such as hypersensitivity pneumonitis, which is not an autoimmune disease, or non-relevant clinical trials . ^[16][17]

Mainstream view

The mainstream medical view is that autoimmune diseases are usually chronic and managed to achieve remission, low disease activity, or organ protection, not universally reversed or cured. In some diseases and in selected patients, sustained remission or even functional cure may occur, especially with disease-specific treatment, removal of triggers, or intensive immune-reset therapies, but this is not the standard expectation across autoimmune diseases and is not established by broad high-quality evidence as a general rule . ^{[17][18][19][20]}

In their own wordsView sourceArchived copy

“Hashimoto's, psoriasis, lupus, and other autoimmune conditions managed by identifying triggers, calming immune reactivity, and restoring tolerance naturally.”

Rule: Minn. Stat. § 148.01, subd. 1

See every doc bro advertising Autoimmune disease

Todd Anderson is not licensed or approved by Minnesota Board of Chiropractic Examiners to diagnose, treat, or cure Leaky gut causes chronic disease.

Leaky gut causes chronic disease

Supports

High-quality evidence shows that increased intestinal permeability (often termed leaky gut or impaired intestinal barrier) is associated with multiple chronic diseases, especially those with inflammatory or autoimmune components. ^[6][22] A 2019 systematic review of intestinal permeability and disease reported increased permeability in a range of conditions including autoimmune disorders, liver disease, diabetes, irritable bowel syndrome, polycystic ovary syndrome, and autism, concluding that intestinal permeability is a potentially significant element linked to a range of health issues and should be considered in pathophysiology and differential diagnosis. ^[21][23] Narrative and systematic reviews from 2023–2025 similarly describe increased intestinal permeability as closely linked to several metabolic and autoimmune systemic diseases, including obesity, nonalcoholic fatty liver disease (NAFLD), cardiovascular disease, inflammatory bowel disease (IBD), type 1 diabetes, and chronic kidney disease, often in the context of dysbiosis, metabolic endotoxemia, and chronic low-grade inflammation. ^[3][4][24] Systematic reviews and meta-analyses show that patients with cardiovascular diseases and chronic kidney disease frequently have markers of increased intestinal permeability, and that gut-directed interventions (prebiotics, probiotics, synbiotics) can modestly reduce some permeability-related markers (such as lipopolysaccharide and zonulin) in RCTs, although with high heterogeneity and often low certainty. Longitudinal and mechanistic work in IBD suggests that increased intestinal permeability can precede Crohn’s disease and that barrier dysfunction, tight junction abnormalities, mucus layer changes, and cytokine-driven disruption are integral parts of IBD pathophysiology, supporting a contributory role of the intestinal barrier in at least some chronic inflammatory diseases. Recent reviews on systemic inflammation and leaky gut note that intestinal hyperpermeability is described across a wide array of chronic conditions and that barrier dysfunction may facilitate translocation of microbial products that sustain systemic inflammation, which is a shared mechanism in many chronic diseases. Overall, there is substantial evidence that intestinal barrier dysfunction is involved in the biology of several specific chronic diseases and that improving barrier integrity can beneficially modify intermediate markers and sometimes symptoms, which partially supports a constrained version of the influencer’s claim (i. e. , that intestinal permeability is relevant to some chronic diseases).

Contradicts

Despite consistent associations, high-quality evidence does not support the broad, causal claim that leaky gut generically “causes chronic disease” across the board. ^[6] Many of the systematic reviews and meta-analyses emphasize that most data are observational, that directionality is unclear (disease may cause permeability changes rather than vice versa), and that confounding by diet, obesity, medications, and underlying inflammation is substantial. ^[23] The certainty of evidence for gut-directed therapies to improve hard clinical outcomes (e. ^[2] g. , major adverse cardiovascular events, progression of chronic kidney disease, long-term autoimmune disease control) is often rated very low under GRADE, with heterogeneous small trials, surrogate endpoints, and high risk of bias. In chronic kidney disease, for example, a major Cochrane review finds it uncertain whether synbiotics, prebiotics, or probiotics meaningfully improve kidney function or major outcomes, despite theoretical benefits on gut barrier and uremic toxins; albuminuria and eGFR changes are small or absent, and the overall quality of evidence is very low. Reviews of metabolic endotoxemia and cardiovascular disease state that while increased permeability and LPS translocation are associated with cardiovascular risk, causality and the clinical utility of targeting intestinal permeability remain unproven, and trials of antibiotic or biotic therapies have produced inconsistent results. ^{[3][21][22][24]} A recent critical review on “leaky gut syndrome” highlights that empiric data convincingly link impaired barrier function to only a limited set of conditions (IBS, functional dyspepsia, IBD, graft-versus-host disease, type 1 diabetes, HIV/AIDS, multiple organ dysfunction syndrome) and explicitly notes minimal to no reliable evidence that leaky gut syndrome is a causative driver of many chronic conditions frequently claimed in lay discussion (such as fibromyalgia, chronic fatigue syndrome, allergies, headache, and brain fog). This directly contradicts broad influencer narratives that leaky gut is the root cause of most chronic disease. Furthermore, guidelines for major chronic conditions (e. g. , hypertension, tension-type headache, pericardial disease) do not treat “leaky gut” as an established causal factor or primary therapeutic target, underscoring that its role is not considered central across chronic disease management. ^[1][4] Overall, existing evidence supports association and mechanistic plausibility in select conditions but does not justify generalized causal claims; the leap from “associated and mechanistically relevant” to “leaky gut causes chronic disease” is not supported by high-quality data.

In their own wordsView sourceArchived copy

“IBS, leaky gut, bloating, SIBO, food sensitivities, and chronic digestive issues addressed at the root”

Rule: Minn. Stat. § 148.01, subd. 1

See every doc bro advertising IBS, SIBO and gut disorders

Todd Anderson is not licensed or approved by Minnesota Board of Chiropractic Examiners to advertise Functional Medicine for Autoimmunity as within their scope of practice.

Functional Medicine for Autoimmunity

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Autoimmunity”

Rule: Minn. Stat. § 148.01, subd. 1

Todd Anderson is not licensed or approved by Minnesota Board of Chiropractic Examiners to diagnose, treat, or cure Digestion & Gut Health.

Digestion & Gut Health

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Digestion & Gut Health”

Rule: Minn. Stat. § 148.01, subd. 1

Todd Anderson is not licensed or approved by Minnesota Board of Chiropractic Examiners to diagnose, treat, or cure Optimize hormones (TRT/peptides implied).

Optimize hormones (TRT/peptides implied)

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Male and female hormone optimization — testosterone, estrogen, progesterone, adrenal health, and DHEA — using functional lab analysis and natural interventions.”

Rule: Minn. Stat. § 148.01, subd. 1

See every doc bro advertising Hormone imbalance and replacement

Todd Anderson is not licensed or approved by Minnesota Board of Chiropractic Examiners to diagnose, treat, or cure Functional Medicine.

Functional Medicine

Supports

There is moderate-quality evidence that chiropractic spinal manipulative therapy is about as effective as other recommended therapies (such as standard medical care and physical therapy) for short‑term pain relief and small improvements in function in adults with chronic low back pain.^[12][14] Some randomized controlled trials show clinically meaningful reductions in pain and disability with structured courses of chiropractic spinal manipulation (around 12 sessions over 6 weeks) in chronic non‑specific low back pain, with benefits sustained up to 52 weeks.^{[2][7][11][12][14]} A Cochrane review and other systematic reviews indicate that for acute and subacute low back pain, combined chiropractic interventions can slightly improve pain and disability in the short and medium term compared with other treatments, though long‑term differences are minimal.^{[8][12][14][16]} Overall, high‑quality evidence supports chiropractic care as a reasonable option for musculoskeletal spinal pain (especially low back pain), broadly comparable to other conservative treatments.^[5][12][14] contradicts

In their own wordsView sourceArchived copy

“Functional Medicine”

Rule: Minn. Stat. § 148.01, subd. 1

Todd Anderson is not licensed or approved by Minnesota Board of Chiropractic Examiners to diagnose, treat, or cure Blood Work Analysis.

Blood Work Analysis

Supports

The influencer’s claim is too vague to directly assess, but general use of blood work (laboratory testing) for diagnosis, risk stratification, and treatment monitoring is strongly supported by mainstream guidelines and high‑quality evidence. ^[6] Hypertension guidelines emphasize the importance of routine blood testing (e. g. , electrolytes, kidney function, lipids) to guide therapy and monitor for treatment adverse effects, integrating lab values into cardiovascular risk assessment and medication choice. ASPEN‑FELANPE nutrition support guidelines explicitly rely on serial laboratory monitoring (electrolytes, liver function tests, blood counts, micronutrient levels) to assess tolerance to parenteral/enteral nutrition and adjust formulations. ^[2] ESPEN guidelines for inflammatory bowel disease specify blood work (including CRP, albumin, hemoglobin, micronutrients) as essential for evaluating disease activity, nutritional status, and complications, and for tailoring clinical nutrition interventions. ^[3] Blood transfusion therapy reviews describe the central role of hemoglobin, hematocrit, platelet count, coagulation tests, and other parameters in determining transfusion thresholds, monitoring response, and minimizing risk. ^[7] Guidelines for other conditions (e. g. , EFNS tension‑type headache, colchicine for pericarditis) incorporate standard blood tests to monitor drug safety (e. ^[4][8] g. , liver function, blood counts) or rule out secondary causes, indicating broad consensus that blood work is a core element of evidence‑based management in diverse diseases. ^[1]

Contradicts

Because the influencer’s claim is not specific (no particular biomarker, threshold, or protocol is described), there is no direct contradiction from the cited index papers. However, major guideline and methodology literature emphasize that blood work should be interpreted within a structured evidence‑based framework and that over‑interpretation of single tests or minor deviations without clinical correlation is not supported. ^[7] GRADE methodology papers stress the need to rate the quality of evidence, account for imprecision, and avoid strong recommendations based solely on weak or indirect laboratory findings. ^[6] Hypertension and nutrition guidelines caution against using blood tests in isolation to make far‑reaching treatment decisions without validated risk models or clinical context, highlighting that routine or extensive “panel‑based” testing beyond guideline‑driven indications may lead to overdiagnosis, unnecessary interventions, and cost without proven benefit. ^[1][2][3][4] There is also no high‑quality evidence supporting broad claims sometimes made by influencers that frequent comprehensive blood panels in otherwise healthy individuals markedly improve outcomes, prevent most diseases, or reliably detect subclinical states that standard guideline‑based testing would miss; such assertions go beyond current data and are considered speculative.

Mainstream view

Mainstream medical practice views blood work as a fundamental diagnostic and monitoring tool, but one that must be ordered and interpreted according to evidence‑based guidelines, clinical context, and validated outcome data. ^[2] Hypertension, nutrition, IBD, neurology, and cardiology guidelines consistently specify which laboratory tests are indicated, at what intervals, and how they should influence management decisions. Major transfusion medicine reviews similarly rely on blood parameters to guide transfusion thresholds, but these thresholds are derived from randomized trials and systematic reviews rather than ad hoc interpretation. ^[7][29] Methodological frameworks like GRADE underscore that lab‑based recommendations should be supported by high‑quality evidence and explicitly address issues of imprecision, benefit–harm balance, and resource use. ^[6] Overall, the mainstream position is that blood work is essential but not sufficient on its own: it should be targeted, guideline‑driven, and integrated with symptoms, physical findings, imaging, and patient preferences, rather than used as an expansive screening tool or as the primary basis for complex therapeutic decisions in the absence of robust supporting evidence. ^[1][4]

In their own wordsView sourceArchived copy

“Blood Work Analysis”

Rule: Minnesota Chiropractic Practice Act (scope limited to musculoskeletal/spine care)

Todd Anderson is not licensed or approved by Minnesota Board of Chiropractic Examiners to diagnose, treat, or cure Hormone Support.

Hormone Support

Supports

The influencer’s claim is extremely vague (“Hormone Support”) and does not specify which hormones, what intervention, or what outcome, so direct evidence “supporting” the claim is limited to general endocrine health principles rather than a specific product or protocol. High‑quality evidence and guidelines across endocrinology consistently support the idea that maintaining overall health through lifestyle modification (balanced diet, regular physical activity, healthy body weight, adequate sleep, and stress management) is beneficial for metabolic and endocrine function, including prevention of type 2 diabetes and cardiovascular disease and improvement of reproductive endocrine disorders like PCOS.^[24] Lifestyle modification is first‑line therapy in several endocrine conditions, such as PCOS, with evidence from randomized and quasi‑experimental studies that structured programs combining diet, exercise, and stress reduction improve quality of life and metabolic/hormonal profiles.^[18][19] Major endocrine and primary‑prevention guidelines for metabolic risk (ASCVD and type 2 diabetes) explicitly recommend lifestyle management as the first priority for patients with metabolic and endocrine risk, which indirectly “supports” the general notion that healthy lifestyle practices are foundational for hormonal health and should precede or accompany any pharmacologic therapy.^[24]

Contradicts

Because the claim is generic (“Hormone Support”) and lacks specifics about the intervention (e.g., particular supplement, diet, bioidentical hormone, cannabis, performance‑enhancing drugs), there is no direct high‑quality evidence validating any specific commercial or influencer‑promoted “hormone support” product or protocol. Umbrella reviews and guidelines emphasize that exogenous hormones or performance‑enhancing drugs in healthy individuals carry significant risks and are not recommended as general wellness or “support” strategies; evidence focuses on disease‑specific indications (e.g., contraception, osteoporosis prevention, ART protocols) rather than broad health optimization.^{[1][2][7][8][23]} The umbrella review of hormonal contraceptives shows associations with several adverse outcomes (e.g., venous thromboembolism, breast cancer) and makes clear these therapies are used for specific indications with risk–benefit balancing, not generic hormone support.^[1][2] Performance‑enhancing drugs in healthy athletes are discussed primarily in terms of harms, side effects, and ethical issues, not as safe or appropriate means of hormonal optimization for the general population.^[7] Major clinical guidelines for endocrine disorders are disease‑focused, with specific diagnostic thresholds, treatment goals, and risk management strategies; they do not endorse unspecific “hormone support” regimens or over‑the‑counter supplement stacks for otherwise healthy people.^{[10][13][14][24]} Many endocrine conditions (e.g., hypertension, diabetes, hypothyroidism, osteoporosis, endometrial cancer risk) require evidence‑based pharmacologic, nutritional, or surgical management according to guidelines rather than unregulated influencer protocols.^{[3][4][15][23][24]} Overall, there is a gap between influencer marketing of broad “hormone support” concepts and the narrow, indication‑specific way hormones are used in mainstream medicine; high‑quality evidence does not support unregulated or non‑indication‑based hormone or supplement use for general wellness.

Mainstream view

Mainstream medical and endocrine practice views hormones as powerful signaling molecules that should be manipulated primarily in the context of clearly defined diagnoses, evidence‑based indications, and guideline‑driven care. Clinical practice guidelines from endocrine societies and related bodies emphasize: (1) accurate diagnosis of specific endocrine disorders; (2) targeted treatment to restore or approximate normal physiological hormone levels; and (3) careful monitoring of risks and adverse effects.^{[10][13][14][24]} For primary prevention and general health, the mainstream position is that maintaining metabolic and endocrine health is best achieved through lifestyle interventions—heart‑healthy dietary patterns, sodium restriction where appropriate, regular physical activity, weight management, smoking avoidance, moderation of alcohol, adequate sleep, and stress reduction—rather than routine use of hormones or hormone‑branded supplements in otherwise healthy individuals.^[11][24][25] Pharmacologic hormones (e.g., contraceptives, menopausal hormone therapy, thyroid hormone, fertility treatments) are used when benefits outweigh risks for specific conditions, with ongoing re‑evaluation based on large trial data, meta‑analyses, and umbrella reviews.^{[1][2][8][23]} There is no broad guideline endorsing generic “hormone support” products; instead, recommendations focus on specific conditions (PCOS, osteoporosis, diabetes, metabolic risk, infertility, adrenal insufficiency, etc.) with tailored interventions that combine lifestyle modification and, when indicated, prescription therapy.^{[10][13][14][15][18][24]}

In their own wordsView sourceArchived copy

“Hormone Support”

Rule: Minn. Stat. § 148.01, subd. 1

See every doc bro advertising Hormone imbalance and replacement

Todd Anderson is not licensed or approved by Minnesota Board of Chiropractic Examiners to diagnose, treat, or cure Specialty Testing.

Specialty Testing

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Specialty Testing”

Rule: Minnesota Chiropractic Practice Act (scope limited to musculoskeletal/spine care)

Todd Anderson is not licensed or approved by Minnesota Board of Chiropractic Examiners to diagnose, treat, or cure Labs & Supplements.

Labs & Supplements

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Labs & Supplements”

Rule: Minn. Stat. § 148.01, subd. 1

Todd Anderson is not licensed or approved by Minnesota Board of Chiropractic Examiners to diagnose, treat, or cure Free Phone Consult.

Free Phone Consult

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Free Phone Consult”

Rule: Minnesota Chiropractic Practice Act (scope limited to musculoskeletal/spine care)

Todd Anderson is not licensed or approved by Minnesota Board of Chiropractic Examiners to advertise Functional Blood Work Analysis as within their scope of practice.

Functional Blood Work Analysis

Supports

The influencer’s claim is too vague to directly assess, but general use of blood work (laboratory testing) for diagnosis, risk stratification, and treatment monitoring is strongly supported by mainstream guidelines and high‑quality evidence. ^[6] Hypertension guidelines emphasize the importance of routine blood testing (e. g. , electrolytes, kidney function, lipids) to guide therapy and monitor for treatment adverse effects, integrating lab values into cardiovascular risk assessment and medication choice. ASPEN‑FELANPE nutrition support guidelines explicitly rely on serial laboratory monitoring (electrolytes, liver function tests, blood counts, micronutrient levels) to assess tolerance to parenteral/enteral nutrition and adjust formulations. ^[2] ESPEN guidelines for inflammatory bowel disease specify blood work (including CRP, albumin, hemoglobin, micronutrients) as essential for evaluating disease activity, nutritional status, and complications, and for tailoring clinical nutrition interventions. ^[3] Blood transfusion therapy reviews describe the central role of hemoglobin, hematocrit, platelet count, coagulation tests, and other parameters in determining transfusion thresholds, monitoring response, and minimizing risk. ^[7] Guidelines for other conditions (e. g. , EFNS tension‑type headache, colchicine for pericarditis) incorporate standard blood tests to monitor drug safety (e. ^[4][8] g. , liver function, blood counts) or rule out secondary causes, indicating broad consensus that blood work is a core element of evidence‑based management in diverse diseases. ^[1]

Contradicts

Because the influencer’s claim is not specific (no particular biomarker, threshold, or protocol is described), there is no direct contradiction from the cited index papers. However, major guideline and methodology literature emphasize that blood work should be interpreted within a structured evidence‑based framework and that over‑interpretation of single tests or minor deviations without clinical correlation is not supported. ^[7] GRADE methodology papers stress the need to rate the quality of evidence, account for imprecision, and avoid strong recommendations based solely on weak or indirect laboratory findings. ^[6] Hypertension and nutrition guidelines caution against using blood tests in isolation to make far‑reaching treatment decisions without validated risk models or clinical context, highlighting that routine or extensive “panel‑based” testing beyond guideline‑driven indications may lead to overdiagnosis, unnecessary interventions, and cost without proven benefit. ^[1][2][3][4] There is also no high‑quality evidence supporting broad claims sometimes made by influencers that frequent comprehensive blood panels in otherwise healthy individuals markedly improve outcomes, prevent most diseases, or reliably detect subclinical states that standard guideline‑based testing would miss; such assertions go beyond current data and are considered speculative.

Mainstream view

Mainstream medical practice views blood work as a fundamental diagnostic and monitoring tool, but one that must be ordered and interpreted according to evidence‑based guidelines, clinical context, and validated outcome data. ^[2] Hypertension, nutrition, IBD, neurology, and cardiology guidelines consistently specify which laboratory tests are indicated, at what intervals, and how they should influence management decisions. Major transfusion medicine reviews similarly rely on blood parameters to guide transfusion thresholds, but these thresholds are derived from randomized trials and systematic reviews rather than ad hoc interpretation. ^[7][29] Methodological frameworks like GRADE underscore that lab‑based recommendations should be supported by high‑quality evidence and explicitly address issues of imprecision, benefit–harm balance, and resource use. ^[6] Overall, the mainstream position is that blood work is essential but not sufficient on its own: it should be targeted, guideline‑driven, and integrated with symptoms, physical findings, imaging, and patient preferences, rather than used as an expansive screening tool or as the primary basis for complex therapeutic decisions in the absence of robust supporting evidence. ^[1][4]

In their own wordsView sourceArchived copy

“Blood Work Analysis”

Rule: Minn. Stat. § 148.01, subd. 1